Abstract
Aqueous humor and serum levels of five beta-adrenergic blockers were measured using gas Chromatographic techniques following ocular instillation of 1% solutions to rabbits. Octanol/buffer partition ratios were also determined. No apparent relationship was found betweeen the peak levels of the agents in aqueous humor and their octanol/buffer partition ratios. However, peak aqueous humor levels of timolol (461 ng/100 mg) and practolol (919 ng/100 mg), whose partition ratios were less than unity, occurred somewhat later (1 h) than the peaks of propranolol (859 ng/100 mg at 30 min), oxprenolol (1,771 ng/100 mg at 30 min) or alprenolol (1,004 ng/ 100 mg at 10 min) whose partition ratios exceeded unity. Peak levels in serum of timolol (8.0 ng/100 μl), propranolol (4.2 ng/100 μl), oxprenolol (11.5 ng/100 μl), and alprenolol (4.5 ng/100 μl) were achieved within 10 min and reduced to less than 15% within 4 h. Peak serum levels of practolol (9.9 ng/100 μl) occurred somewhat later (2 h) and remained high (41%) 6 h later.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benson H (1974) Permeability of the cornea to topically applied drugs. Arch Ophthalmol 91:313–327
Boger WP, Steinert RF, Puliafito CA, Pavan-Langston D (1978) Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Am J Ophthalmol 86:8–18
Bonomi L, Perfetti S, Noya E, Belluci R, Massa F (1979) Comparison of the effects of nine beta-adrenergic blocking agents on intra-ocular pressure in rabbits. Albrecht von Graefes Arch Klin Ophthalmol 210:1–8
Bonomi L, Steindler P (1975) Effect of pindolol on intraocular pressure. Br J Ophthalmol 59:301–303
Bucci MG (1977) Effects of new topical beta-mimetic (isoxuprine and nylidine) and beta-lytic (oxprenolol) agents on the ocular pressure in glaucomatous eyes. Ophthal Res 9:238–246
Bucci MG, Pecori-Giraldi J, Missiroli A, Virno M (1968) The topical administration of propranolol in the treatment of glaucoma. Boll Oculist 47:51–60
Dean RB, Dixon WJ (1951) Simplified statistic for small number of observations. Analyt Chem 23:636–638
Degen PH, Riess W (1976) Simplified method for the determination of oxprenolol and other beta-receptor blocking agents in biological fluids by gas-liquid chromatography. J Chromatog 121:72–75
Elliot MJ, Cullen PM, Phillips CI (1975) Ocular hypotensive effect of atenolol (Tenormin ICI). A new beta-adrenergic blocker. Br J Ophthalmol 59:296–300
Frishman W (1979) Clinical pharmacology of the new beta-adrenergic blocking drug. Part 1: pharmacodynamic and pharmacokinetic properties. Am Heart J 97:663–670
Hamard H, Schmitt C, Plazonnet B, Le Douarec JC (1975) Etude de la pénétration oculaire de la dexaméthasone. In: Demailly Ph, Hamard H, Luton JP (ed) Oeil et cortisone. Masson & Cie, Paris, pp 33–83
Katz I (1979) Efficacy and safety of long-term maintenance treatment with timolol ophthalmic solution in chronic open-angle glaucoma. Klin Mbl Augenheilk 175:225–231
Kiechel JR, Meier J (1978) Pharmacocinétique comparée des béta-bloquants. La Nouvelle Presse Médicale 7:2685–2687
Phillips CI, Howitt G, Rowlands J (1967) Propranolol as ocular hypotensive agent. Br J Ophthalmol 51:222–226
Ros FE, Dake CL, Nagelkerke NSD, Greve EL (1978a) Metoprolol eye drops in the treatment of glaucoma. A double-blind single-dose trial of a beta1 adrenergic blocking drug. Albrecht von Graefes Arch Klin Ophthalmol 206:247–254
Ros FE, Dake CL, Offerhaus L, Greve EL (1977) Atenolol 4% eyedrops and glaucoma. A double-blind short-term clinical trial of a new beta1 adrenergic blocking agent. Albrecht von Graefes Arch Klin Ophthalmol 205:61–70
Ros FE, Innemee HC, Van Zwieten PA (1978b) Penetration of atenolol in the rabbit eye. Albrecht von Graefes Arch Klin Ophthalmol 208:235–240
Ros FE, Innemee HC, Van Zwieten PA (1979) Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Documenta Ophthalmologica 48:291–301
Rowland JM, Potter DE (1980) Adrenergic drugs and intraocular pressure: Suppression of ocular hypertension induced by water loading. Exp Eye Res 30:93–104
Schmitt C, Lotti VJ, Le Douarec JC (1980) Penetration of timolol into the rabbit eye after ocular instillation and intravenous injection. Arch Ophthalmol 98:547–551
Tocco DJ, De Luna FA, Duncan AEW (1975a) Electron capture determination of timolol in human plasma and urine. J Pharm Sci 64:1879–1881
Tocco DJ, Duncan AEW, De Luna FA, Hucker HB, Gruber VF, Vandenheuvel WJA (1975b) Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Disp 3:361–370
Vale J, Gibbs ACC, Phillips CI (1972) Topical propranolol and ocular tension in the human. Br J Ophthalmol 56:770–775
Vale J, Phillips CI (1973) Practolol (Eraldin) eye drops as an ocular hypotensive agent. Br J Ophthalmol 57:210–214
Vareilles P, Silverstone D, Plazonnet B, Le Douarec JC, Sears ML, Stone CA (1977) Comparison of the effect of timolol and other adrenergic agents on intra-ocular pressure in the rabbit. Invest Ophthalmol Vis Sci 16:987–996
Zimmerman TJ, Kaufman HE (1977) Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 95:601–604
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitt, C., Lotti, V.J. & Le Douarec, J.C. Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation. Albrecht von Graefes Arch. Klin. Ophthalmol. 217, 167–174 (1981). https://doi.org/10.1007/BF00411147
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00411147